Endocrine Testing Market Size Likely To Reach USD 13.02 Billion By 2024

Posted by Neha Bora on September 20th, 2019

San Francisco, 20 September 2019: The Report Endocrine Testing Market Size, Share & Trends Analysis Report By Test Type, By Technology (Tandem Mass Spectrometry, Immunoassay), By End-use And Segment Forecasts, 2018 – 2024

The global endocrine testing market is expected to reach USD 13.02 billion by 2024, according to a new report by Grand View Research, Inc. Increasing geriatric population and growing rate of diseases such as obesity and diabetes is expected to drive the market growth.

The presence of a large population over 60 years, having lower immunity levels and are prone to neurological diseases, cardiac problems, cancers, and spinal injuries, is a high impact-rendering driver for the growth of endocrine testing market over the forecast period.

Sedentary lifestyles of people with unhealthy food habits and increasing stress levels resulted in an increase in the diabetic and obese population. This demographic is highly susceptible to endocrine diseases and is anticipated to contribute to industry growth substantially.

Technological advancements in terms of accuracy and affordability resulted in an increased usage of these tests. For instance, the influx of test kits, for home-based testing has fostered the demand for these techniques, helping the market to grow. Advancement in technology ensures diagnosis in less time and faster initiation of treatment.

Software have been designed to manage the workflow in the laboratories. Newer mobile apps have been introduced wherein a patient can be reminded about his appointment or test, and he will be able to contact physician whenever he wants. These advancements in technology is anticipated to propel the market growth over the forecast period.

Access Research Report of Endocrine Testing Market www.grandviewresearch.com/industry-analysis/endocrine-testing-market

Further key findings from the report suggest:

  • The global thyroid stimulating hormone testing market is anticipated to reach 3.6 billion by 2024, at a CAGR of 10.2% from 2016 to 2024
  • In terms of test type, insulin test is expected to show the fastest growth over the forecast period
  • In terms of technology, Tandem Mass Spectrometry (TMS) held the largest share in 2016 and is expected to dominate the market during the forecast period
  • In terms of technology, sensor technology is expected to show the fastest growth during the forecast period
  • North America is expected to dominate the market followed by Europe and Asia Pacific region
  • Asia Pacific is projected to drive the market growth and provide numerous opportunities to industry players. Key factors attributed to market growth include growing R&D expenditure by the government and private agencies in order to improve diagnostic and therapeutic areas in the region
  • Some of the key companies present in the market include Abbott Laboratories, AB Sciex, Agilent Technologies, Biomedical Technologies, bioMerieux SA, Bio Rad Laboratories, DiaSorin, Hoffmann-La Roche Ltd., LabCorp, and Quest Diagnostics.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/clinical-diagnostics

Grand View Research has segmented the global endocrine testing market report on the basis of test type, technology, end use, and region:

Test Type Outlook (Revenue, USD Million, 2013 - 2024)

  • Estradiol
  • FSH
  • hCG
  • LH
  • Progesterone
  • Testosterone
  • TSH
  • Prolactin
  • Cortisol
  • Insulin
  • Others

Technology Outlook (Revenue, USD Million, 2013 - 2024)

  • Tandem Mass Spectrometry
  • Immunoassay
  • Monoclonal & Polyclonal antibody technologies
  • Sensor technology
  • Clinical chemistry
  • Others

End Use Outlook (Revenue, USD Million, 2013 - 2024)

  • Hospital
  • Commercial Laboratory
  • Ambulatory Care Centers
  • Others

Regional Outlook (Revenue, USD Million, 2013 - 2024)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA

Access Press Release of Endocrine Testing Market www.grandviewresearch.com/press-release/global-endocrine-testing-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.



Like it? Share it!

Neha Bora

About the Author

Neha Bora
Joined: September 16th, 2019
Articles Posted: 2,017

More by this author